Drug Type Small molecule drug |
Synonyms N-Valproylglycinamide, Valproyl glycinamide, Valrocemide (USAN/INN) + [7] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H20N2O2 |
InChIKeyRALGCAOVRLYSMA-UHFFFAOYSA-N |
CAS Registry92262-58-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Phase 2 | US | - | - |
Epilepsy | Phase 2 | HU | - | - |
Epilepsy | Phase 2 | GB | - | - |
Epilepsy | Phase 2 | - | - | |
Epilepsy | Phase 2 | - | - | |
Epilepsy | Phase 2 | - | - | |
Epilepsy | Phase 2 | - | - |